Hilary Eaton

R&D

Hilary Eaton, a rare disease advocate and chief business officer at Profluent, discusses AI-first protein design and accelerating biomedicine.

News

A PCR diagnostic developed by Roche for the Bundibugyo form of Ebola is being offered to health systems at the front lines of the current outbreak.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.